Showing results (181-190 of 1,919) with videos related to
Sort By:
Pageof 192
Cancer Biomarkers : Section a of Disease Markers|July 18, 2020
lncRNA GAS8-AS1 genetic alterations in papillary thyroid carcinoma and their clinical significanceDa-Lei Zhou, Qing Liu, Bo-Heng Xu, et al.Cancer Biomarkers : Section a of Disease Markers|July 28, 2020
Prognostic value of post-radiation serum squamous cell carcinoma antigen and primary tumor regression for cervical squamous cell carcinomaQuan Wan, Wangxiang Yan, Yonghong Liu, et al.Cancer Biomarkers : Section a of Disease Markers|July 28, 2020
Pre-surgical level of von Willebrand factor as an evident indicator of breast cancer recurrencePiotr Rhone, Elżbieta Zarychta, Kornel Bielawski, et al.Cancer Biomarkers : Section a of Disease Markers|July 28, 2020
miR-199a-5p suppresses epithelial- mesenchymal-transition in anaplastic thyroid carcinoma cells via targeting Snail signalsFengyun Hao, Ya-Nan Bi, Lei Wang, et al.Cancer Biomarkers : Section a of Disease Markers|July 6, 2020
Identification of genes in hepatocellular carcinoma induced by non-alcoholic fatty liver diseaseChangzhou Cai, Xin Song, Chaohui YuCancer Biomarkers : Section a of Disease Markers|July 6, 2020
The clinical significance of interleukin 24 and its potential molecular mechanism in laryngeal squamous cell carcinomaXiao-Zhun Tang, Xian-Guo Zhou, Xiao-Guohui Zhang, et al.Cancer Biomarkers : Section a of Disease Markers|July 6, 2020
Screening and identification of key biomarkers in alimentary tract cancers: A bioinformatic analysisZeling Cai, Yi Wei, Shuai Chen, et al.Cancer Biomarkers : Section a of Disease Markers|July 6, 2020
Serum interleukin-8 as a potential diagnostic biomarker in esophageal squamous cell carcinomaZeting Huang, Bin Zhou, Zheng Li, et al.Cancer Biomarkers : Section a of Disease Markers|April 26, 2021
Prognostic significance of preoperative systemic immune-inflammation index in combined hepatocellular-cholangiocarcinomaFeng Zhang, Ke-Shu Hu, Shen-Xin Lu, et al.Cancer Biomarkers : Section a of Disease Markers|April 26, 2021
KCNN4 promotes the progression of lung adenocarcinoma by activating the AKT and ERK signaling pathwaysPing Xu, Xiao Mo, Ruixue Xia, et al.Pageof 192